This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
How to Invest After the Market Selloff
by Sejuti Banerjea
Tried and tested methods always work best when you're faced with increased uncertainty and volatility.
Humana (HUM) Up 3.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna and Dignity Health Sign New Deal to Serve Patients
by Zacks Equity Research
Cigna's (CI) collaboration with Dignity Health intends to provide improved health outcomes for the California and Nevada communities.
5 Top-Ranked Stocks Picked on DuPont Analysis
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Humana (HUM) Taps Salesforce for Better Healthcare Services
by Zacks Equity Research
Humana (HUM) teams up with Salesforce to provide improved healthcare services for its members.
Humana (HUM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Humana (HUM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
Zacks.com featured highlights include: MED, SYX, USNA, HUM and XPEL
by Zacks Equity Research
Zacks.com featured highlights include: MED, SYX, USNA, HUM and XPEL
Play DuPont Technique to Bet on 5 Top-Ranked Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
by Zacks Equity Research
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on an upbeat outlook and rising membership, Anthem (ANTM) holds immense potential to reap benefits for investors.
Solid Near-Term HMO Industry Prospects on Multiple Tailwinds
by Sapna Bagaria
Health insurers are on a solid ground, given rising demand for Medicare policies, led by the increasing baby boomer population.
Here's Why Investors Should Bet on Select Medical Stock Now
by Zacks Equity Research
Select Medical (SEM) remains well-poised for growth on the back of improving revenues, strategic buyouts and impressive capital position.
3 Health Insurers That Surpass the S&P 500 Year to Date
by Srijita Guha
We zero in on three health insurers that have managed to outperform the broader index year to date, banking on core strength.
The Zacks Analyst Blog Highlights: Chesapeake Utilities, UGI Corp., Humana, Flowers Foods and B&G Foods
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chesapeake Utilities, UGI Corp., Humana, Flowers Foods and B&G Foods
Play Safe as Fed Paints a Gloomy Economic Outlook: 5 Picks
by Tirthankar Chakraborty
With the markets gyrating on Fed's cautious view, investors should build a strategy on low-risk assets and a combination of parameters that lead to better returns.
Anthem, Quest Tie up to Improve Healthcare Across the US
by Zacks Equity Research
Anthem (ANTM) teams up with Quest in order to improve health outcomes to consumers with the help of their innovative solutions.
Here's Why You Should Add Humana (HUM) to Your Portfolio
by Zacks Equity Research
Riding high on its Medicare line of business and strategic initiatives, Humana (HUM) holds enough potential to reap benefits for investors.
Molina Healthcare (MOH) Surges 44.1% YTD: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) rising membership is likely to boost its revenues, which in turn, might perk up in share price.
Cigna Banks on Diversified Business, Solid Capital Position
by Zacks Equity Research
Cigna's (CI) prolific business profile creates a steady revenue recovery trajectory while its solid financial footing enables reinvestment in business
Teladoc Health to Merge With Livongo to Improve Services
by Zacks Equity Research
Teladoc Health (TDOC) to merge with Livongo in a cash-stock deal valued at $18.5 billion, which is likely to result in improved virtual healthcare services.
Company News for Aug 6, 2020
by Zacks Equity Research
Companies In The News Are: ATH, HUM, BIP, W.
Humana's (HUM) Q2 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) Q2 earnings reflect better revenues and solid contributions from its Retail and Healthcare Services segments.
Acadia Healthcare (ACHC) Q2 Earnings Top Estimates, Fall Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 earnings are hurt year over year by lower patient days and revenue per patient day, partly offset by decreased expenses.
Humana (HUM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 21.47% and 2.52%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?